Elevance Health Inc (ELV) support and resistance · P/E 18, rev $199.13B
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
This page maps Elevance Health Inc (ELV) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
ELV currently screens at market cap $90.24B and trailing P/E 17.6. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ELV 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ELV quote page for the session range and the stock page for the full model.
Not investment advice.